News

GE Healthcare and Intel Corporation have expanded their sales and marketing agreement for the Intel Health Guide to include the UK. GE Healthcare already markets the Intel Health

Immunodiagnostic Systems (IDS) has reported that Italy-based Technogenetics has signed a five year distribution agreement with A Menarini Diagnostics (Menarini) covering Europe for an automated test system, the

Microfluidic Systems (MFSI) has been awarded a series of patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens

Pearl Therapeutics (Pearl) has reported positive results from phase 2a dose-ranging study of PT005, a formoterol fumarate hydrofluoroalkane metered dose inhaler (HFA-MDI) formulation, in patients with chronic obstructive

Winner Medical Group (Winner Medical) has opened its first three PurCotton pilot chain stores in Shenzhen, Guangdong province, China. At the same time, its subsidiary, Winner Industries (Shenzhen)

Hennepin County Medical Center (HCMC) has reported that a five-year study of patients with severe traumatic brain injury. The study conducted at HCMC in Minneapolis shows significant benefit

Ranbaxy Labroratories (Ranbaxy) has launched a new chemical entity (NCE), Lulifin (Luliconazole), in the Indian dermatology market following a strategic in-licencing agreement with Summit Pharmaceuticals International (SPI) that

Zydus Cadila has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials for the H1N1 (swine flu) vaccine. The egg based, inactivated vaccine

Optigenex has entered into a long term exclusive license agreement with Promethean for distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11. AC-11 is a